documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
37 rows where docket_id = "FDA-1978-N-0018" and posted_year = 2015 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1978-N-0018-0807 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Attachments 1, 2 and 4 re: Supplement from Merck KGaA | Supporting & Related Material | Background Material | 2015-03-30T04:00:00Z | 2015 | 3 | 2019-08-09T14:13:22Z | 0 | 0 | 090000648055a66e | |||
| FDA-1978-N-0018-0806 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from Personal Care Products Council and Consumer Healthcare Products Association to FDA CDER | Other | Letter(s) | 2015-03-20T04:00:00Z | 2015 | 3 | 2015-03-20T04:00:00Z | 2015-03-20T16:22:32Z | 0 | 0 | 0900006481a549c3 | ||
| FDA-1978-N-0018-0802 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 27 - Guidance for Industry, S1B Testing for Carcinogenicity of Pharmaceuticals, July 1997 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:21Z | 0 | 0 | 0900006481a1130c | |||
| FDA-1978-N-0018-0805 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 30 - International Conference on Harmonization (ICH) Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies S3A, March 1995 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:50Z | 0 | 0 | 0900006481a11044 | |||
| FDA-1978-N-0018-0788 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 13 - Schreurs et al, Estrogenic Activity of UV Filters Determined by an In Vitro Reporter Gene Assay and an In Vivo Transgenic Zebrafish Assay re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:02Z | 0 | 0 | 0900006481a112c8 | |||
| FDA-1978-N-0018-0794 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 19 - Faas et al, Female Sexual Behavior, Estrous Cycle and Gene Expression in Sexually Dimorphic Brain Regions After Pre- and Postnatal Exposure to Endocrine Active UV Filters re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:03Z | 0 | 0 | 0900006481a112ce | |||
| FDA-1978-N-0018-0775 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T05:00:00Z | 2015-04-14T03:59:59Z | 2015-04-14T02:11:05Z | 2015-03884 | 0 | 0 | 0900006481a1641f |
| FDA-1978-N-0018-0780 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 5 - Janjua et al, Sunscreens in Human Plasma and Urine After Repeated Whole-Body Topical Application re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:45Z | 0 | 0 | 0900006481a10e87 | |||
| FDA-1978-N-0018-0785 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 10 - Mueller et al, Activation of Estrogen Receptor Alpha and ERbeta by 4-Methylbenzylidene-Camphor in Human and Rat Cells: Comparison With Phyto- and Xenoestrogens re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:35Z | 0 | 0 | 0900006481a112c5 | |||
| FDA-1978-N-0018-0795 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 20 - Hofkamp et al, Region-Specific Growth Effects in the Developing Rat Prostate Following Fetal Exposure to Estrogenic Ultraviolet Filters re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:12Z | 0 | 0 | 0900006481a11305 | |||
| FDA-1978-N-0018-0797 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 22 - Maerkel et al, Sex- and Region-Specific Alterations of Progesterone Receptor mRNA Levels and Estrogen Sensitivity in Rat Brain Following Developmental Exposure to the Estrogenic UV Filter 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:36Z | 0 | 0 | 0900006481a11307 | |||
| FDA-1978-N-0018-0798 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 23 - Schlumpf et al, In Vitro and In Vivo Estrogenicity of UV Screens re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:47Z | 0 | 0 | 0900006481a11308 | |||
| FDA-1978-N-0018-0790 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 15 - Soeborg et al, Risk Assessment of Topically Applied Products re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:20Z | 0 | 0 | 0900006481a112ca | |||
| FDA-1978-N-0018-0804 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 29 - International Conference on Harmonization (ICH) Harmonized Tripartite Guideline for Industry, Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S5(R2), 2005 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:41Z | 0 | 0 | 0900006481a1130e | |||
| FDA-1978-N-0018-0779 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 4 - Schauer, et al, Kinetics of 3-(methylbenzlidene) Camphor in Rats and Humans After Dermal Application re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:38Z | 0 | 0 | 0900006481a10e86 | |||
| FDA-1978-N-0018-0777 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 2 - FDA, Guidance for Industry, Guideline for the Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application, February 1987 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:22Z | 0 | 0 | 0900006481a10e84 | |||
| FDA-1978-N-0018-0778 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 3 - Janjua, et al Systemic Absorption of the Sunscreens Benzophenone-3, Octyl-Methoxycinnamate, and 3-(4-Methyl-Benzylidene) Camphor After Whole Body Topical Application and Reproductive Hormone Levels in Humans re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:30Z | 0 | 0 | 0900006481a10e85 | |||
| FDA-1978-N-0018-0787 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 12 - Schmutzler et al, Endocrine Disruptors and the Thyroid Gland-A Combined In Vitro and In Vivo Analysis of Potential New Biomarkers re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:54Z | 0 | 0 | 0900006481a112c7 | |||
| FDA-1978-N-0018-0796 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 21 - Maerkel et al, Sexually Dimorphic Gene Regulation in Brain as a Target for Endocrine Disrupters: Developmental Exposure of Rats to 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:27Z | 0 | 0 | 0900006481a11306 | |||
| FDA-1978-N-0018-0786 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 11 - Schlumpf et al, Estrogenic Activity and Estrogen Receptor Beta Binding of the UV Filter 3-Benzylidene Camphor. Comparison With 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:46Z | 0 | 0 | 0900006481a112c6 | |||
| FDA-1978-N-0018-0783 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 8 - Gomez et al, Estrogenic Activity of Cosmetic Components in Reporter Cell Lines: Parabens, UV Screens and Musks re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:16Z | 0 | 0 | 0900006481a10e8a | |||
| FDA-1978-N-0018-0784 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 9 - Ma et al, UV Filters With Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:26Z | 0 | 0 | 0900006481a10e8b | |||
| FDA-1978-N-0018-0791 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 16 -Tinwell et al, Confirmation of Uterotrophic Activity of 3-(4-Methylbenzylidine) Camphor in the Immature Rat re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:32Z | 0 | 0 | 0900006481a112cb | |||
| FDA-1978-N-0018-0799 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 24 - Schlumpf et al, Estrogenic Activity and Estrogen Receptor Beta Binding of the UV Filter 3-Benzylidene Camphor. Comparison With 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:36:57Z | 0 | 0 | 0900006481a11309 | |||
| FDA-1978-N-0018-0801 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 26 - International Conference on Harmonization (ICH), Guidance for Industry, The Need for Long Term Rodent Carcinogenicity Studies of Pharmaceuticals S1A, March 1996 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:14Z | 0 | 0 | 0900006481a1130b | |||
| FDA-1978-N-0018-0803 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 28 - International Conference on Harmonization (ICH) Guidance for Industry - S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals SIC(R2) (Revision 1), September 2008 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:33Z | 0 | 0 | 0900006481a1130d | |||
| FDA-1978-N-0018-0781 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 6 - Scientific Committee on Consumer Products (SCCP)/1184/08-SCCNFP Opinion on 4-Methylbenzylidene Camphor (4-MBC) Colipa n° S60 Adopted During the 16th Plenary Meeting of June 24, 2008 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:55Z | 0 | 0 | 0900006481a10e88 | |||
| FDA-1978-N-0018-0782 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 7- Jimenez-Diaz et al, Simultaneous Determination of the UV-Filters Benzyl Salicylate, Phenyl Salicylate, Octyl Salicylate, Homosalate, 3-(4-Methylbenzylidene) Camphor and 3-Benzylidene Camphor in Human Placental Tissue by LC-MS/MS. Assessment of Their In Vitro Endocrine Activity re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:34:05Z | 0 | 0 | 0900006481a10e89 | |||
| FDA-1978-N-0018-0789 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 14 - Seidlova Wuttke et al, Comparison of Effects of Estradiol With Those of Octylmethoxycinnamate and 4-Methylbenzylidene Camphor on Fat Tissue, Lipids and Pituitary Hormones re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:12Z | 0 | 0 | 0900006481a112c9 | |||
| FDA-1978-N-0018-0776 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 1 - FDA, Guidance for industry, Photosafety Testing, May 2003 re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:33:10Z | 0 | 0 | 0900006481a10e83 | |||
| FDA-1978-N-0018-0792 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 17 - Durrer et al, Estrogen Sensitivity of Target Genes and Expression of Nuclear Receptor Co-Regulators in Rat Prostate After Pre- and Postnatal Exposure to the Ultraviolet Filter 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:41Z | 0 | 0 | 0900006481a112cc | |||
| FDA-1978-N-0018-0793 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 18 - Durrer et al, Estrogen Target Gene Regulation and Coactivator Expression in Rat Uterus After Developmental Exposure to the Ultraviolet Filter 4-Methylbenzylidene Camphor re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:35:52Z | 0 | 0 | 0900006481a112cd | |||
| FDA-1978-N-0018-0800 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Reference 25 - Schlumpf et al, Endocrine Activity and Developmental Toxicity of Cosmetic UV Filters-An Update re Over-the-Counter Sunscreen Drug Products—Regulatory Status of Enzacamene | Supporting & Related Material | Background Material | 2015-02-25T05:00:00Z | 2015 | 2 | 2015-02-25T17:37:05Z | 0 | 0 | 0900006481a1130a | |||
| FDA-1978-N-0018-0774 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Slide Presentation from the Sunscreen Innovation Act Stakeholder Meeting re Meeting Announcement from FDA CDER re FDA Implementation of the Sunscreen Innovation Act (SIA), February 4 2015, FDA-1978-N-0018-0772 | Supporting & Related Material | Meeting Materials | 2015-02-23T05:00:00Z | 2015 | 2 | 2015-02-24T04:43:32Z | 0 | 0 | 0900006481a10372 | |||
| FDA-1978-N-0018-0773 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Summary of Meeting re Meeting Announcement from FDA CDER re FDA Implementation of the Sunscreen Innovation Act SIA February 4 2015, FDA-1978-N-0018-0772 | Supporting & Related Material | Meeting Summary | 2015-02-23T05:00:00Z | 2015 | 2 | 2015-02-24T04:44:20Z | 0 | 0 | 0900006481a1036f | |||
| FDA-1978-N-0018-0772 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Meeting Announcement from FDA CDER re FDA Implementation of the Sunscreen Innovation Act (SIA), February 4 2015 | Other | Memorandum | 2015-01-26T05:00:00Z | 2015 | 1 | 2015-01-26T05:00:00Z | 2015-02-24T04:46:31Z | 0 | 0 | 09000064819e06e0 | ||
| FDA-1978-N-0018-0771 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from The Proprietary Association to FDA | Other | Letter(s) | 2015-01-05T05:00:00Z | 2015 | 1 | 2019-08-09T17:54:57Z | 0 | 0 | 09000064805596c4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);